FindTrial
Sign In

A nove model for predicting ICGR15 based on clinical parameters

Developing and validating a model to predict ICGR15 based on clinical testing and pathology data

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100050791
Enrollment
Unknown
Registered
2021-09-04
Start date
2021-09-10
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative liver failure

Interventions

case series:NA

Sponsors

Renji Hospital Affiliated to Medical College of Shanghai Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. At least 18 years old; 2. Pathological diagnosis of hepatocellular carcinoma; 3. The ICG clearance rate was detected within 7 days before surgery.

Exclusion criteria

Exclusion criteria: 1. There are malignant tumors in other parts at the same time; 2. The length of liver tissue is less than 15mm.

Design outcomes

Primary

MeasureTime frame
collagen proportionate area;Albumin-bilirubin score;total bile acids;prealbumin;Direct bilirubin;alkaline phosphatase;Fibrinogen;gamma-glutamyltransferase;Age;gender;—

Countries

China

Contacts

Public ContactXue Feng

Renji Hospital, Shanghai Jiaotong University School of Medicine

fengxue6879@163.com+86 19821839020

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026